Ligand Pharma (LGND) Tops Q3 EPS by 6c, Offers FY20 and FY21 Guidance

Go back to Ligand Pharma (LGND) Tops Q3 EPS by 6c, Offers FY20 and FY21 Guidance
LIGAND PHARMA (NASDAQ: LGND) Delayed: 243.28 +5.53 (2.33%)
Previous Close $237.75    52 Week High $139.79 
Open $241.98    52 Week Low $82.07 
Day High $245.00    P/E 565.77 
Day Low $237.00    EPS $0.43 
Volume 173,529